Ignite Creation Date:
2024-05-06 @ 2:22 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02023359
Status:
COMPLETED
Last Update Posted:
2015-12-29
First Post:
2013-12-23
Brief Title:
Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor HR Positive Human Epidermal Growth Factor 2 HER2 - Metastatic Breast Cancer
Sponsor:
Novartis Healthcare AS
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12
Start Date Type:
None
Primary Completion Date:
2015-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-23
First Submit QC Date:
December 23 2013
Study First Post Date:
2013-12-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-26
Last Update Post Date:
2015-12-29
Last Update Post Date Type:
ESTIMATED